În afara temei aiqbench
Această știre a fost preluată de la o sursă pe care o urmărim, dar nu ține de domeniul AI sau cuantic, așa că nu există o perspectivă aiqbench pentru ea.
TianenKang: Wholly-owned Subsidiary Receives Drug Registration Certificate for Diquafosol Ophthalmic Solution
36Kr reports that TianenKang announced its wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., recently received the Drug Registration Certificate for Diquafosol Ophthalmic Solution issued by the National Medical Products Administration. The Diquafosol Ophthalmic Solution is indicated for dry eye patients diagnosed with corneal and conjunctival epithelial damage accompanied by tear film abnormalities.
Citește articolul complet pe 36KrSubiecte conexe
Tianen Kang: Receives Drug Registration Certificate for Polidocanol Injection
36Kr · 16 oct. 2026
KQC Quantum and Charlton Aria Agree on Nasdaq Business Combination
The Quantum Insider · 7 oct. 2026
Stock Market Today Highlights, Sept 2: Sensex ends 373 pts lower at 76, 570, Nifty below 24, 000; Asian Paints, HDFC Bank fall most
thehindubusinessline.com · 2 sept. 2026
Baiyunshan Receives Drug Registration Certificate for Irbesartan and Hydrochlorothiazide Tablets
36Kr · 9 oct. 2026